CVS:NYE-CVS Health Corporation (USD)

EQUITY | Healthcare Plans | New York Stock Exchange

Last Closing

USD 62.88

Change

+1.50 (+2.44)%

Market Cap

USD 78.05B

Volume

0.02B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

CVS Health Corp iis an integrated pharmacy health care provider. The Company has three segments: Pharmacy Services, Retail Pharmacy and Corporate.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

+2.83 (+0.49%)

USD 530.79B
ELV Elevance Health Inc

-3.95 (-0.75%)

USD 121.50B
CNC Centene Corp

+0.70 (+0.94%)

USD 38.77B
MOH Molina Healthcare Inc

+2.70 (+0.79%)

USD 19.84B
OSCR Oscar Health Inc

+0.22 (+1.05%)

USD 5.25B
NEUE NeueHealth Inc

+0.11 (+2.15%)

USD 0.05B
CI Cigna Corp

-1.26 (-0.36%)

N/A
HUM Humana Inc

-2.83 (-0.89%)

N/A

ETFs Containing CVS

WBIY WBI Power Factor® High D.. 4.72 % 0.70 %

+0.07 (+0.00%)

USD 0.06B
UNCU:LSE First Trust US Equity Inc.. 2.97 % 0.00 %

-0.11 (0.00%)

USD 0.04B
UINC:LSE First Trust US Equity Inc.. 2.88 % 0.00 %

-6.50 (0.00%)

USD 0.31B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

-0.04 (0.00%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

-0.02 (0.00%)

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.01 (+0.00%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.21 (+0.00%)

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.03 (+0.00%)

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

N/A

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

+0.06 (+0.00%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.31B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

-0.12 (0.00%)

USD 0.99B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.01 (+0.00%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

+0.01 (+0.00%)

USD 0.08B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

+0.22 (+0.00%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

-0.15 (0.00%)

USD 0.65B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

-0.28 (0.00%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

-0.06 (0.00%)

USD 1.02B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

+0.01 (+0.00%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

-0.13 (0.00%)

USD 2.87B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

-0.05 (0.00%)

USD 2.24B
RTH VanEck Retail ETF 0.00 % 0.35 %

+0.51 (+0.00%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

+0.20 (+0.00%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

-0.03 (0.00%)

USD 2.12B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

+0.38 (+0.00%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

+0.01 (+0.00%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

-1.50 (0.00%)

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.36% 19% F 9% A-
Dividend Return 2.53% 90% A- 48% F
Total Return -17.84% 19% F 10% F
Trailing 12 Months  
Capital Gain -9.77% 19% F 12% F
Dividend Return 3.73% 90% A- 51% F
Total Return -6.04% 19% F 13% F
Trailing 5 Years  
Capital Gain 2.24% 8% B- 46% F
Dividend Return 18.07% 88% B+ 62% D
Total Return 20.32% 8% B- 45% F
Average Annual (5 Year Horizon)  
Capital Gain 3.20% N/A N/A 50% F
Dividend Return 5.99% N/A N/A 50% F
Total Return 2.78% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.30% N/A N/A 39% F
Risk Adjusted Return 22.76% N/A N/A 41% F
Market Capitalization 78.05B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Healthcare Plans) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 15.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.